Daratumumab (anti-CD38)

Ask supplier a question | View on supplier's website

Daratumumab (anti-CD38) is a recombinant monoclonal antibody to CD38. Daratumumab is an investigational anti-cancer drug which is indicated for the treatment of adult patients with multiple myeloma. MW =145.4 kDa.

Supplier	Selleck Chemicals
Product #	A2027
Sku #	A2027-1mg*5
Pricing	1mg*5, $707.00

Feedback